2017
Serum Neurofilament light: A biomarker of neuronal damage in multiple sclerosis
Abstract: ObjectiveNeurofilament light chains (NfL) are unique to neuronal cells, are shed to the cerebrospinal fluid (CSF), and are detectable at low concentrations in peripheral blood. Various diseases causing neuronal damage have resulted in elevated CSF concentrations. We explored the value of an ultrasensitive single‐molecule array (Simoa) serum NfL (sNfL) assay in multiple sclerosis (MS).MethodssNfL levels were measured in healthy controls (HC, n = 254) and two independent MS cohorts: (1) cross‐sectional with pair…
Search citation statements
Paper Sections
Select...
758
268
237
80
Citation Types
93
1,242
15
22
Year Published
2000
2026
Publication Types
Select...
1,000
64
52
20
Relationship
191
945
Authors
Journals
Cited by 1,093 publications
(1,375 citation statements)
References 53 publications
93
1,242
15
22
“…Our analysis demonstrated that serum levels of the investigated molecular biomarkers did not predict the progression of physical disability defined by any of the three different EDSS-based criteria (see the Methods section). These results remain in contrast with several previous studies showing correlation between serum NfL levels and disability progression in PMS patients [ 7 , 63 ]. Also, CSF levels of NfL and/or YKL-40 were suggested as predictors of neurological disability accumulation in progressive MS patients [ 27 , 62 ].…”
Section: Discussioncontrasting
confidence: 99%
“…Our analysis demonstrated that serum levels of the investigated molecular biomarkers did not predict the progression of physical disability defined by any of the three different EDSS-based criteria (see the Methods section). These results remain in contrast with several previous studies showing correlation between serum NfL levels and disability progression in PMS patients [ 7 , 63 ]. Also, CSF levels of NfL and/or YKL-40 were suggested as predictors of neurological disability accumulation in progressive MS patients [ 27 , 62 ].…”
Section: Discussioncontrasting
confidence: 99%
“…These measures did not show a significant correlation (Spearman correlation (r s ) = −0.107, p = n.s. ), in line with findings by others 4,10 . We therefore did not consider this variable in further analysis.…”
Section: Resultssupporting
confidence: 94%
“…12,20,21 Our cross-sectional analyses confirm previous reports stating that sNfL concentrations are associated with clinical disability and cognitive performance, the number of T2 lesions, T2 lesion volume and the presence of new T2 lesions. 2,5,22,23 However, we found no significant associations between sNfL and normalized brain volume measures, in contrast to what was observed by Barro et al 8 One explanation for this could be that our patient population had lower disability scores at baseline and were treated with more highly effective DMTs. In addition, the follow-up time was relatively short.…”
Section: Discussioncontrasting
confidence: 95%
